Literature DB >> 23329904

Review.

Constantine Soulellis1, Nir Hilzenrat.   

Abstract

Year:  2007        PMID： 23329904      PMCID： PMC3099328     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  12 in total

1.  Small bile duct abnormalities in sarcoidosis.

Authors:  J R Murphy; M H Sjogren; J W Kikendall; D A Peura; Z Goodman
Journal:  J Clin Gastroenterol       Date:  1990-10       Impact factor: 3.062

2.  Infliximab therapy for hepatic and intestinal sarcoidosis.

Authors:  Helen S Te; Lucas Campbell; Saima Chohan
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-06

Review 3.  Sarcoidosis.

Authors:  Robert P Baughman; Elyse E Lower; Roland M du Bois
Journal:  Lancet       Date:  2003-03-29       Impact factor: 79.321

Review 4.  Diagnosis and management of neurosarcoidosis.

Authors:  F C Vinas; S Rengachary
Journal:  J Clin Neurosci       Date:  2001-11       Impact factor: 1.961

5.  The clinical management of sarcoidosis. A 50-year experience at the Johns Hopkins Hospital.

Authors:  C J Johns; T M Michele
Journal:  Medicine (Baltimore)       Date:  1999-03       Impact factor: 1.889

6.  The effect of corticosteroid or methotrexate therapy on lung lymphocytes and macrophages in sarcoidosis.

Authors:  R P Baughman; E E Lower
Journal:  Am Rev Respir Dis       Date:  1990-12

7.  TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection.

Authors:  Daniel R Roach; Andrew G D Bean; Caroline Demangel; Malcolm P France; Helen Briscoe; Warwick J Britton
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

8.  Hepatic sarcoidosis. Clinicopathologic features in 100 patients.

Authors:  K Devaney; Z D Goodman; M S Epstein; H J Zimmerman; K G Ishak
Journal:  Am J Surg Pathol       Date:  1993-12       Impact factor: 6.394

9.  Colonic obstruction secondary to sarcoidosis: nonsurgical diagnosis and management.

Authors:  N Hilzenrat; A Spanier; E Lamoureux; C Bloom; A Sherker
Journal:  Gastroenterology       Date:  1995-05       Impact factor: 22.682

10.  Tumour necrosis factor alpha inhibitor treatment for sarcoidosis refractory to conventional treatments: a report of five patients.

Authors:  C Pritchard; K Nadarajah
Journal:  Ann Rheum Dis       Date:  2004-03       Impact factor: 19.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.